Identification and characterization of a novel scFv recognizing human and mouse CD133

Immunotoxin targeting CD133+ breast carcinoma cells

(2012) John R. Ohlfest et al.   Drug Delivery and Translational Research

CD133 ProteinN-Glycosylation Processing Contributes to Cell Surface Recognition of the Primitive Cell Marker AC133 Epitope

(2011) Anthony B. Mak et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer

(2011) Davide Pellacani et al.   Molecular Cancer

Targeting Tumor-Initiating Cancer Cells with dCD133KDEL Shows Impressive Tumor Reductions in a Xenotransplant Model of Human Head and Neck Cancer

(2011) N. N. Waldron et al.   MOLECULAR CANCER THERAPEUTICS

The AC133 Epitope, but not the CD133 Protein, Is Lost upon Cancer Stem Cell Differentiation

(2010) K. Kemper et al.   CANCER RESEARCH

Pancreatic Cancer Cells Resistant to Chemoradiotherapy Rich in “Stem-Cell-Like” Tumor Cells

(2010) Zhiyong Du et al.   DIGESTIVE DISEASES AND SCIENCES

Identification of a novel monoclonal antibody recognizing CD133

(2010) Suresh Kumar Swaminathan et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Therapeutic implications of colon cancer stem cells

(2010) Eros Fabrizi   WORLD JOURNAL OF GASTROENTEROLOGY

De novo Induction of Genetically Engineered Brain Tumors in Mice Using Plasmid DNA

(2009) S. M. Wiesner et al.   CANCER RESEARCH

Cell Cycle-Dependent Variation of a CD133 Epitope in Human Embryonic Stem Cell, Colon Cancer, and Melanoma Cell Lines

(2008) M. Jaksch et al.   CANCER RESEARCH

The Role of CD133 in Normal Human Prostate Stem Cells and Malignant Cancer-Initiating Cells

(2008) D. J. Vander Griend et al.   CANCER RESEARCH

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells

(2008) Scott Bidlingmaier et al.   JOURNAL OF MOLECULAR MEDICINE-JMM